Curcumin Protects Against Ischemia/Reperfusion Injury in Rat Skeletal Muscle

被引:84
作者
Avci, Gulden [1 ]
Kadioglu, Huseyin [2 ]
Sehirli, Ahmet O. [3 ]
Bozkurt, Suleyman [2 ]
Guclu, Oguz [4 ]
Arslan, Emrah [1 ]
Muratli, Sedit K. [5 ]
机构
[1] Educ & Res Hosp, Fac Med, Dept Plast & Reconstruct Surg, Canakkale, Turkey
[2] Bezmialem Univ, Fac Med, Dept Surg, Istanbul, Turkey
[3] Marmara Univ, Fac Pharm, Dept Pharmacol, Istanbul, Turkey
[4] Canakkale Onsekiz Mart Univ, Fac Med, Dept Otorhinolaryngol, Canakkale, Turkey
[5] Canakkale Onsekiz Mart Univ, Fac Med, Dept Orthoped & Traumatol, Canakkale, Turkey
关键词
ischemia-reperfusion injury; skeletal muscle; curcumin; reactive oxygen species;
D O I
10.1016/j.jss.2011.08.021
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. Curcumin has been shown to decrease ischemia-reperfusion (I/R) injury in kidney or brain tissues. In this study, the effects of curcumin were evaluated in skeletal muscle during I/R injury. Materials and Methods. Hind limb ischemia was induced by clamping the common femoral artery and vein. After 4 h ischemia, the clamp of the femoral vessels of animals was taken off and the animal underwent 2 h reperfusion. We measured plasma concentrations of interleukin-1 beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) using enzyme-linked immunosorbent assay (ELISA). The right gastrocnemius muscle was harvested and immediately stored at -30 degrees C for the assessment of superoxide dismutase (SOD), catalase (CAT) activities, and measurement of glutathione (GSH), malondialdehyde (MDA), and protein oxidation (PO) levels. Curcumin (100 mg/kg), alpha-tocopherol, and normal saline (10 mL /kg1) were administered intraperitoneally 1 h prior reperfusion. Results. Plasma TNF-alpha or IL-1 beta levels increased significantly in I/R group. The plasma levels of these proinflammatory cytokines were reduced in curcumin group. Muscle tissues of I/R groups revealed significantly higher antioxidant enzyme (superoxide dismutase, glutathione peroxidase, catalase) activities, and increased levels of malondialdehyde, nitric oxide, and protein carbonyl content compared with the SHAM group. Levels of these parameters in muscle revealed significant reductions in the I/R D curcumin group compared witho the I/R group. Curcumin has more potent antioxidant activity than vitamin E in the skeletal muscle I/R. Conclusion. In this study, protective effects of curcumin against skeletal muscle ischemia-reperfusion injury have been revealed. We underscore the necessity of human studies with curcumin that would be hypothetically beneficial preventing skeletal muscle I/R injury. Crown Copyright (C) 2012 Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:E39 / E46
页数:8
相关论文
共 58 条
[1]   Curcumin inhibition of inflammatory cytokine production by human peripheral blood monocytes and alveolar macrophages [J].
Abe, Y ;
Hashimoto, S ;
Horie, T .
PHARMACOLOGICAL RESEARCH, 1999, 39 (01) :41-47
[2]   Ischemia/reperfusion injury [J].
Anaya-Prado, R ;
Toledo-Pereyra, LH ;
Lentsch, AB ;
Ward, PA .
JOURNAL OF SURGICAL RESEARCH, 2002, 105 (02) :248-258
[3]  
[Anonymous], 1974, Catalase. Methods Enzym. Anal., DOI DOI 10.1016/B978-0-12-091302-2.50032-3
[4]  
Appell H.J., 1999, Basic Appl. Myol, V9, P263
[5]   Immune-adhesion molecules in the prevention of allograft rejection and reperfusion injury [J].
Behrend, M .
EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (04) :789-805
[6]   THE ROLE OF LEUKOCYTES IN THE PATHO-PHYSIOLOGY OF SKELETAL-MUSCLE ISCHEMIC-INJURY [J].
BELKIN, M ;
LAMORTE, WL ;
WRIGHT, JG ;
HOBSON, RW .
JOURNAL OF VASCULAR SURGERY, 1989, 10 (01) :14-19
[7]  
Bierhaus A, 1997, THROMB HAEMOSTASIS, V77, P772
[8]   METHODOLOGY FOR ANALYSIS OF TISSUE SULFHYDRYL COMPONENTS [J].
BOYNE, AF ;
ELLMAN, GL .
ANALYTICAL BIOCHEMISTRY, 1972, 46 (02) :639-&
[9]  
Buege J A, 1978, Methods Enzymol, V52, P302
[10]   Erythropoietin protects against brain ischemic injury by inhibition of nitric oxide formation [J].
Calapai, G ;
Marciano, MC ;
Corica, F ;
Allegra, A ;
Parisi, A ;
Frisina, N ;
Caputi, AP ;
Buemi, M .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2000, 401 (03) :349-356